GLOW 70 mg
GLOW combines GHK-Cu, BPC-157 and TB-500 in a three-peptide research formulation. Its components are investigated in studies of extracellular matrix signaling, vascular responses and cell movement, providing a basis for research into their combined activity.
BPC-157 + TB-500 10 mg
This blend combines BPC-157 and TB-500 in equal proportions. Research investigates how these two peptides relate to inflammatory signaling, vascular responses and cytoskeletal activity, including their potential interactions in experimental models of tissue repair.
BPC-157 + TB-500 20 mg
This blend combines BPC-157 and TB-500 in equal proportions. Research investigates how these two peptides relate to inflammatory signaling, vascular responses and cytoskeletal activity, including their potential interactions in experimental models of tissue repair.
CJC-1295 without DAC + Ipamorelin 10 mg
This 10 mg blend contains 5 mg of CJC-1295 without DAC and 5 mg of Ipamorelin. It combines a GHRH analogue with a ghrelin receptor agonist for research into their coordinated effects on growth hormone signaling.
KLOW 80 mg
KLOW combines GHK-Cu, BPC-157, TB-500 and KPV in a four-peptide research formulation. Its components are investigated in studies of inflammatory signaling, vascular activity and extracellular matrix regulation, supporting research into combined peptide interactions.